Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Published Online
on October 2, 2009

Circulation: Arrhythmia and Electrophysiology. 2009
Published online before print October 2, 2009, doi: 10.1161/CIRCEP.109.863118
This Article
Right arrow Full Text (PDF)
Right arrow Editor Note
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cutler, M. J.
Right arrow Articles by Rosenbaum, D. S.
PubMed
Right arrow Articles by Cutler, M. J.
Right arrow Articles by Rosenbaum, D. S.
Related Collections
Right arrow Gene therapy
Right arrow Arrythmias-basic studies
Right arrow Calcium cycling/excitation-contraction coupling

Original Article

Targeted SERCA2a Gene Expression Identifies Molecular Mechanism and Therapeutic Target for Arrhythmogenic Cardiac Alternans

Michael J. Cutler1; Xiaoping Wan1; Kenneth R. Laurita1; Roger J. Hajjar2 and David S. Rosenbaum1,3

1 Case Western Reserve University, Cleveland, OH;
2 Mount Sinai School of Medicine, New York, NY

* Corresponding author; email: drosenbaum{at}metrohealth.org

Background—Beat to beat alternans of cellular repolarization is closely linked to ventricular arrhythmias in humans. We hypothesized that sarcoplasmic reticulum calcium reuptake by SERCA2a plays a central role in the mechanism of cellular alternans and increasing SERCA2a gene expression will retard the development of cellular alternans.

Methods and ResultsIn-vivo gene transfer of a recombinant adenoviral vector with the transgene for SERCA2a (Ad.SERCA2a) was performed in young guinea pigs. Isolated myocytes transduced with Ad.SERCA2a exhibited improved sarcoplasmic reticulum Ca2+ reuptake (p< 0.05) and were markedly resistant to Ca-ALT (p< 0.05) under repetitive constant action potential clamp conditions (i.e. when APD-ALT was prevented) proving that SR Ca2+ cycling is an important mechanism in the development of cellular alternans. Similarly, SERCA2a overexpression in the intact heart demonstrated significant resistance to APD-ALT when compared control hearts (HR threshold 484±25 bpm vs 396±11 bpm, p< 0.01), with no change in APD restitution slope. Importantly, SERCA2a overexpression produced a 4-fold reduction in susceptibility to alternans-mediated ventricular arrhythmias (p< 0.05).

Conclusions—These data provide new evidence that SR Ca2+ reuptake directly modulates susceptibility to cellular alternans. Moreover, SERCA2a overexpression suppresses cellular alternans, interrupting an important pathway to cardiac fibrillation in the intact heart.

Key Words: action potentials • arrhythmia • gene therapy • alternans • intracellular calcium • adenoviral gene transfer • repolarization